Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 524654 | NSE Symbol : NATCAPSUQ | ISIN : INE936B01015 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
05-Feb-2025	12-Feb-2025	Quarterly Results	NATURAL CAPSULES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 inter alia to consider and approve 1. the Unaudited Consolidated & Standalone Financial Results of the Company for the Quarter ended December 31st 2024. 2. Any other matters with the permission of the Chairman. Pursuant to the SEBI (Prohibition of Insider Trading) Regulations 2015 and the Companys Code of Conduct for Prevention of Insider Trading and Code of Corporate Disclosure Practices we wish to inform that the Trading Window for dealing in the equity shares of the Company has remained closed for all Designated Person and their immediate relatives w.e.f. 01st January 2025 till the conclusion of 48 hours after the declaration of financial results of the Company for the Quarter ended 31st December 2024. This is to inform that Board of Directors at their meeting held on 12.02.2025 have approved unaudited financial results for the quarter ended 31.12.2024 This is to inform that the Board of the Directors at their meeting held on Wednesday, February 12th, 2025, have Approved the unaudited Standalone and Consolidated Financial Results for .. (As Per BSE Announcement dated on 12.02.2025)
04-Nov-2024	12-Nov-2024	Quarterly Results	NATURAL CAPSULES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) 2015 we wish to inform that 163rd meeting of the Board of Directors of the Company is scheduled on Tuesday November 12 2024 to consider and take on record inter-alia the following items: 1. To Consider and approve the Unaudited Consolidated & Standalone Financial Results of the Company for the Quarter and half year ended September 30 2024. 2. To discuss on listing of equity shares of company in National Stock Exchange (NSE). 3. Any other matters with the permission of the Chairman. This is to inform that the Board of the Directors at their meeting held on Tuesday, November 12th, 2024, have: 1. Approved the unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2024. 2. Approved for making application for listing of securities of the company on National stock exchange (NSE). 3. The Nomination Renumeration & Compensation Committee (NRC) of the company have approved the allotment of a total of 30,000 (Thirty Thousand) Equity shares of face value Rs.10/- each fully paid up against the exercise of vested Options of Employee stock option plan 2018. The Board Meeting commenced at 03.30 PM and concluded at 05.40 PM. (As per BSE Announcement Dated on 12/11/2024)
02-Sep-2024	05-Sep-2024	Preferential Issue	NATURAL CAPSULES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) 2015 notice is hereby given that a meeting of Board of Directors of the Company will be held on Thursday September 5 2024 to inter alia; to consider and allot upto 912917 equity shares of face value of Rs.10/- each at a issue price of Rs.320/- each including a Premium of Rs.310/- each on preferential basis. The Special resolution has been passed in the Extra-Ordinary general meeting held on 23rd August 2024 and In Principle approval has been received from BSE Limited vide Letter No: LOD/PREF/DA/FIP/782/2024-25 dated 22nd August 2024. We hereby inform that the Board of the Directors of the company at their meeting held on Thursday, September 05, 2024, Pursuant to Regulation 30 of SEBI (Listing Obligations and disclosure requirements) Regulations,2015 have Approved the allotment of 9,12,917 fully paid -up equity shares of face value Rs.10/- (Rupees Ten only each) at an Issue price of Rs.320 /- (Rupees Three hundred twenty only) each including premium of Rs.310/- each (Rupees Three hundred ten only) aggregating to Rs.29,21,33,440/-(Rupees Twenty Nine crores Twenty One Lakhs Thirty Three Thousand Four hundred Forty only) to Non-Promoters on Preferential basis through resolution passed in the Extra-Ordinary general meeting held on 23rd August 2024 and for which In Principle approval has been received from BSE vide Letter No: LOD/PREF/DA/FIP/782/2024-25 dated 22nd August,2024. Read less.. (As Per BSE Announcement Dated on 05.09.2024)
05-Aug-2024	13-Aug-2024	Quarterly Results	NATURAL CAPSULES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) 2015 We wish to inform that a meeting of the Board of Directors of the company is scheduled on Tuesday 13th day of August 2024 to consider and take on record inter-alia the following items: 1.To consider and approve the Unaudited Consolidated & Standalone Financial Results of the company for the Quarter ended 30th June 2024; 2. Any other matters. Pursuant to the SEBI (Prohibition of Insider Trading) Regulations 2015 and the companys code of conduct for prevention of Insider Trading and Code of Corporate Disclosure Practices We wish to inform that the Trading Window for dealing in the equity shares of the company has remained closed for all designated person and their immediate relatives w.e.f. 01st July 2024 till the conclusion of 48 hours after the declaration of financial results of the company for the quarter ended 30th June 2024. This is to inform that the Board of Directors at their meeting held on tuesday, 13.08.2024, have considered the Retirement of Mr. C P Rangachar, Chairman of the Company pursuant to completion of his tenure on 24.08.2024 and approved the additional charge of office as new Chairman of the Company of Mr. Tekkar Yashwanth Prabhu wef 25.08.2024. This is to inform that the Board of the Directors at their meeting held on Tuesday, August 13, 2024, have: 1. Approved the unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2024; 2. Considered the retirement of Mr. Cattan Coletore Padmanabhan Rangachar, DIN: 00310893 (Chairman and Non-executive Independent Director) pursuant to completion of his tenure on August 24th, 2024. 3. Considered and approved the additional charge of office as new Chairman of the Company alongwith current designation of Mr. Tekkar Yashwanth Prabhu, DIN: 02113527 (Non-executive Independent Director), with effect from 25th Aug 2024. 4. Approved the reconstitution of various committees, viz with effect from 25th Aug 2024. 5. The Nomination Renumeration & Compensation Committee (NRC) and Board have approved following ESOP grant under NCL ESOP 2018, the general terms and conditions of the grant The Board Meeting commenced at 04.00 PM and concluded at 05.45 PM. (As per BSE Announcement dated on 13/08/2024)
23-Jul-2024	26-Jul-2024	Preferential Issue	NATURAL CAPSULES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) 2015 notice is hereby given that a meeting of Board of Directors of the Company will be held on Friday July 26 2024 to inter alia; consider and approve the proposal for raising funds by way of issue of Equity Shares through Preferential Issue Private Placements or combination thereof as may be permitted under applicable laws subject to such regulatory/statutory approvals as may be required including the approval of the shareholders of the Company. We wish to inform you that the Board of Directors of Natural Capsules Limited, at its meeting held today i.e. on July 26, 2024, has considered and approved, subject to shareholders approval, the issuance of 9,12,917 (Nine Lakhs Twelve Thousand Nine Hundred and Seventeen) fully paid-up equity shares of the Company having face value of Rs.10/- each aggregating to an amount not exceeding Rs. 29,21,33,440 (Rupees Twenty Nine Crore Twenty One Lakh Thirty Three Thousand Four Hundred Forty only) on a preferential basis ('Preferential Issue') (As Per BSE Announcement dated on 26.07.2024) With reference to our intimation dated 26.07.2024, we wish to inform that, due to inadvertence we had wrongly mentioned one of the proposed investors names as Malti Narendra Sampat instead of Narendra Dharmsinh Sampat (HUF). However, Board had approved the correct Proposed allottee name only i.e. Narendra Dharmsinh Sampat (HUF). Due to oversight the name was wrongly mentioned in the outcome filed on 26.07.2024. We hereby resubmit the revised outcome. Request you to kindly take the same on records. (As per BSE Announcement Dated on 30/07/2024)
19-Jun-2024	19-Jun-2024	Change in Directors	This is to inform that the Board of the Directors at their meeting held on Wednesday, June 19, 2024, have: 1.Approved the Appointment of Additional Non-Executive Independent Director of the Company. 2.Approved the Forfeiture of partly paid-up Rights Equity Shares of the Company allotted pursuant to the Letter of Offer dated October 30, 2021. The meeting commenced at 02.30 PM and concluded at 03.20 PM.
15-May-2024	21-May-2024	Dividend	NATURAL CAPSULES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2024 inter alia to consider and approve Pursuant to Regulation of the SEBI (Listing Obligations and Disclosure Requirements) 2015 We wish to inform that a meeting of the Board of Directors of the company is scheduled on Tuesday 21st day of May 2024 to consider and take on record inter-alia the following items: 1.To consider and approve the Audited Consolidated & Standalone Financial Results of the company for the Quarter & Financial Year ended March 31st 2024; 2.To Consider and recommend dividend if any for the Financial year ended March 31st 2024; 3. Any other matters. This is to inform that the Board of the Directors at their meeting held on Tuesday, May 21, 2024, have: 1. Approved the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2024; 2. Decided not to recommend dividend considering the need for conservation of internal resources to meet expansion requirements; 3. Date & timings for ensuing Annual General Meeting of the Company shall be intimated in due course of time; 4. Reappointed Mr. Sunil L Mundra (DIN:00214304) as Managing director of the company, subject to shareholders approval; 5. Approved the appointment of Mr. Parthasarathy, Company Secretary as Secretarial Auditor; 6. Approved the appointment of M/S. Mallya & Mallya, Chartered Accountants as Internal Auditors; (As Per BSE Announcement dated on 21.05.2024)
29-Apr-2024	29-Apr-2024	Change in Directors	Pursuant to Regulation 30, SEBI (LODR), we would like to inform you that the Board of directors at their meeting held on 29.04.2024, based on the recommendation of NRC, have approved the reappointment of Mr. Pramod Kasat as an additional and independent director, subject to shareholders approval. The required details are enclosed herewith.
02-Feb-2024	09-Feb-2024	Quarterly Results	NATURAL CAPSULES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) 2015 we wish to inform that 156th meeting of the Board of Directors of the Company is scheduled on Friday 9th February 2024 to consider and take on record inter-alia the following items: 1. To Consider and approve the Unaudited Consolidated & Standalone Financial Results of the Company for the Quarter ended December 31 2023; 2. Any other matters with the permission of the Chairman. This is to inform that the Board of Directors at their meeting held today i.e., 09.02.2024, have: 1. Considered and Approved Unaudited Standalone & Consolidated Financial Results for the Quarter ended 31st December 2023; The Board Meeting Commenced at 03.30 PM and concluded at 05.30 PM Kindly take the aforesaid information on Record in Compliance of SEBI (Listing obligation and Disclosure Requirements), Regulation 2015 (As per BSE Announcement Dated on 09/02/2024)
02-Nov-2023	09-Nov-2023	Quarterly Results	NATURAL CAPSULES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) 2015 we wish to inform that 155th meeting of the Board of Directors of the Company is scheduled on Thursday9th day of November 2023 to consider and take on record inter-alia the following items: 1. To Consider and approve the Unaudited Consolidated & Standalone Financial Results of the Company for the Quarter & Half Year ended September 30th 2023; 2. Any other matters with the permission of the Chairman. This is to inform that the Board of Directors at their meeting held today i.e., 09.11.2023, have: Considered & Approved Unaudited Standalone & Consolidated Financial Results for the Quarter & half year ended 30th September 2023 The Board Meeting Commenced at 03.30 PM and concluded at 04.45 PM Kindly take the aforesaid information on Record in Compliance of SEBI (Listing obligation and Disclosure Requirements), Regulation 2015 (As per BSE Announcement Dated on 09/11/2023)
02-Aug-2023	09-Aug-2023	Quarterly Results	NATURAL CAPSULES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2023 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) 2015 we wish to inform that a meeting of the Board of Directors of the Company is scheduled on Wednesday 9th day of August 2023 to consider and take on record inter-alia the following items: 1. To Consider and approve the Unaudited Consolidated & Standalone Financial Results of the Company for the Quarter ended June 30th 2023; 2. Any other matters with the permission of the Chairman. Pursuant to the SEBI (Prohibition of Insider Trading) Regulations 2015 and the Companys Code of Conduct for Prevention of Insider Trading and Code of Corporate Disclosure Practices we wish to inform that the Trading Window for dealing in the equity shares of the Company has remained closed for all Designated Person and their immediate relatives w.e.f. 01st July 2023 till the conclusion of 48 hours after the declaration of financial results of the Company for the Quarter ended 30th June 2023. A. This is to inform that the Board of the Directors at their meeting held today, i.e. Wednesday, August 9, 2023, have: 1. Approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2023. 2. Approved sending Reminder cum forfeiture notice to the holders of such partly paid-up equity shares who have failed to pay the First Call, Second & Final call or both the Call Monies on the following terms: 1 Call payment period Begins on August 17, 2023 Ends on August 31, 2023 2 Period available to pay 15 days 3 Rate of interest for delayed payment 8% p.a. 4 Acceptable modes of payment Demand Draft 5 Detailed instructions Will form part of the Final Reminder cum Forfeiture Notice and shall be uploaded on the Company''s website viz., www.naturalcapsules.com in due course. B. The Board Meeting commenced at 04.00 PM and concluded at 06.50 PM. (As per BSE Announcement Dated on 09/08/2023)
19-May-2023	26-May-2023	Accounts	NATURAL CAPSULES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2023 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) 2015 we wish to inform that a meeting of the Board of Directors of the Company is scheduled on Friday the 26th day of May 2023: 1. To Consider and approve the Audited Consolidated & Standalone Financial Results of the Company for the Quarter & Financial Year ended March 31st 2023; 2. To consider declaration of Dividend on the equity shares of the Company; Pursuant to the SEBI (Prohibition of Insider Trading) Regulations 2015 and the Companys Code of Conduct for Prevention of Insider Trading and Code of Corporate Disclosure Practices we wish to inform that the Trading Window for dealing in the equity shares of the Company has remained closed for all Designated Person and their immediate relatives w.e.f. 01st April 2023 till the conclusion of 48 hours after the declaration of financial results of the Company for the Quarter and Financial year ended 31st March 2023. A. This is to inform that the Board of the Directors at their meeting held today, i.e. Friday, May 26, 2023, have: 1. Approved the Audited Standalone and Consolidated Financial Results for the quarter and Financial year ended March 31, 2023. 2. Recommended dividend @ 10% i.e. Rs. 0.10/- per equity share of Rs. 10/- each subject to the approval of the shareholders at the ensuing 30th Annual General Meeting (AGM) of the Company; 3. Record date for the entitlement of Dividend, and date & timings for ensuing Annual General Meeting of the Company shall be intimated in due course of time. A. This is to inform that the Board of the Directors at their meeting held today, i.e. Friday, May 26, 2023, have: 1. Approved the Audited Standalone and Consolidated Financial Results for the quarter and Financial year ended March 31, 2023. 2. Recommended dividend @ 10% i.e. Rs. 1/- per equity share of Rs. 10/- each subject to the approval of the shareholders at the ensuing 30th Annual General Meeting (AGM) of the Company; 3. Record date for the entitlement of Dividend, and date & timings for ensuing Annual General Meeting of the Company shall be intimated in due course of time. (As Per BSE Announcement Dated on 26/05/2023) Revised outcome- Further to our intimation dated 26.05.2023, due to inadvertence, there were some typing errors on consolidated Financial Results and dividend amount per equity share. We hereby submit the revised outcome of Board Meeting. A. This is to inform that the Board of the Directors at their meeting held on Friday, May 26, 2023, have: 1. Approved the Audited Standalone and Consolidated Financial Results for the quarter and Financial year ended March 31, 2023. 2. Recommended dividend @ 10% i.e. Re. 1/-(one) per equity share of Rs. 10/- (ten) each subject to the approval of the shareholders at the ensuing 30th Annual General Meeting (AGM) of the Company; 3. Record date for the entitlement of Dividend, and date & timings for ensuing Annual General Meeting of the Company shall be intimated in due course of time. Further to our intimation dated 26.05.2023, due to inadvertence, there were some typing errors on consolidated Financial Results and dividend amount per equity share. We hereby submit the revised outcome of Board Meeting. A. This is to inform that the Board of the Directors at their meeting held on Friday, May 26, 2023, have: 1. Approved the Audited Standalone and Consolidated Financial Results for the quarter and Financial year ended March 31, 2023. 2. Recommended dividend @ 10% i.e. Re. 1/-(one) per equity share of Rs. 10/- (ten) each subject to the approval of the shareholders at the ensuing 30th Annual General Meeting (AGM) of the Company; 3. Record date for the entitlement of Dividend, and date & timings for ensuing Annual General Meeting of the Company shall be intimated in due course of time. (As Per BSE Announcement Dated on 27.05.2023)
03-Feb-2023	13-Feb-2023	Quarterly Results	NATURAL CAPSULES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve 1. To Consider and approve the Unaudited Consolidated & Standalone Financial Results of the Company for the Quarter ended December 31st 2022. 2. To consider any other matter as the Board may think fit; Pursuant to the SEBI (Prohibition of Insider Trading) Regulations 2015 and the Companys Code of Conduct for Prevention of Insider Trading and Code of Corporate Disclosure Practices we wish to inform that the Trading Window for dealing in the equity shares of the Company has remained closed for all Designated Person and their immediate relatives w.e.f. 01st January 2023 till the conclusion of 48 hours after the declaration of financial results of the Company for the Quarter ended 31st December 2022. A. This is to inform that the Board of the Directors at their meeting held today, i.e. Monday, February 13, 2023, have: Approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended December 31, 2022. B. The Board Meeting commenced at 03.00 PM and concluded at 05.45 PM. A. This is to inform that the Board of the Directors at their meeting held today, i.e. Monday, February 13, 2023, have: Approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended December 31, 2022. B. The Board Meeting commenced at 03.00 PM and concluded at 05.45 PM. (As Per BSE Announcement dated on 13.02.2023)
21-Oct-2022	28-Oct-2022	Quarterly Results	NATURAL CAPSULES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2022 inter alia to consider and approve 1. To Consider and approve the Unaudited Consolidated & Standalone Financial Results of the Company for the Quarter & half Year ended September 30th 2022; 2. To discuss on making further call on balance right issue money; Pursuant to the SEBI (Prohibition of Insider Trading) Regulations 2015 and the Companys Code of Conduct for Prevention of Insider Trading and Code of Corporate Disclosure Practices we wish to inform that the Trading Window for dealing in the equity shares of the Company has remained closed for all Designated Person and their immediate relatives w.e.f. 01st October 2022 till the conclusion of 48 hours after the declaration of financial results of the Company for the Quarter and half year ended 30th September 2022. A. This is to inform that the Board of the Directors at their meeting held today, i.e. Friday, October 28, 2022, have: 1. Approved the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2022. 2. Approval on making balance 50% right issue second & final call money. Outcome of Board Meeting held on October 28, 2022 A. This is to inform that the Board of the Directors at their meeting held today, i.e. Friday, October 28, 2022, have: 1. Approved the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2022. 2. Approval on making balance 50% right issue second & final call money. Approval on making balance 50% right issue second & final call money. Please refer the Letter of Offer ('LoF') dated October 30, 2021, whereby the Company Issued 31,16,350 Equity Shares on Rights Basis to tie eligible Shareholders as on Record Date. The Issue Price was Rs. 100.00 per Equity Share (Application money Rs. 25/- per share & 1st call money Rs. 25/- per share). Further the Company at its Board Meeting held on October 28, 2022, have decided for Second & Final call Money and the details are hereunder: Second & Final Call: Rs. 50.00 per Equity Share (Rs. 5/- towards Face Value and 45/- towards premium) Record Date: 10.11.2022 Payment Period: First day to pay call money: 21.11.2022 Last day to pay call money: 05.12.2022 (As Per BSE Announcement Dated on 28.10.2022) With reference to the captioned subject, We hereby inform that, Unaudited Financial Results for the quarter ended 30th September, 2022 has been published in Business Line-An English daily & Sanjevani- a Kannada daily. (As Per BSE Announcement Dated on 09/11/2022)
03-Aug-2022	10-Aug-2022	Quarterly Results	NATURAL CAPSULES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2022 inter alia to consider and approve 1. To Consider and approve the Unaudited Consolidated & Standalone Financial Results of the Company for the Quarter ended June 30 2022; 2. To consider any other matter as the Board may think fit. Pursuant to the SEBI (Prohibition of Insider Trading) Regulations 2015 and the Companys Code of Conduct for Prevention of Insider Trading and Code of Corporate Disclosure Practices we wish to inform that the Trading Window for dealing in the equity shares of the Company has remained closed for all Designated Person and their immediate relatives w.e.f. July 01 2022 till the conclusion of 48 hours after the declaration of Unaudited financial results of the Company for the Quarter ended June 30 2022. We request you to kindly take the aforesaid information on record for dissemination through your website. A. This is to inform that the Board of the Directors at their meeting held today, i.e. Wednesday, August 10, 2022, have: 1. Approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2022. 2. Considered resignation of Mr. Anjan Kumar Roy from the services of the Company as Independent Director. 3. Considered and approved Appointment of Mr. S. G. Belapure as additional director (Independent) of the Company with immediate effect, to hold office up to the date of ensuing Annual General Meeting ('AGM') of the Compan, subject to approval of the members at the ensuing AGM of the Company, Mr. S. G. Belapure shall hold office as an Independent director for a period of 5 (five years) with immediate effect. 4. To fix date of AGM as 20th,September 2022. 5. Outcome of Nomination, Remuneration & Compensation Committee (As Per BSE Announcement dated on 10.08.2022)

1 2

LOGIN HERE

Natural Capsules Ltd

Board Meeting